Insider trades
Nikhil Lalwani, CEO of Ani Pharmaceuticals ANIP, has filed 0 purchases and 9 sales on the open market. Over the past 12 months that comes to a net sale of $4.3M. The latest trade was on 05/11.
Nikhil Lalwani
President & CEO
- Company
- Ani Pharmaceuticals ANIP
- First filing
- 23/03/09
- Trades
- 37 trades
- Buys / sales
- 0 / 9
- 12-month net buying
- −$4.3M
- Last trade
- 05/11
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale | 05/11 | 05/13 | 55,000 sh | $77.57 | $4,266,350 | −13.6% | |
| Open-market sale | 25/08/12 | 25/08/14 | 56,960 sh | $85.93 | $4,894,572.8 | −12.2% | |
ANIP | Open-market sale | 24/11/26 | 24/11/27 | 33,481 sh2 trades | $57.99avg. | $1,941,442.3 | −8.3% |
| Open-market sale | 24/05/14 | 24/05/16 | 16,669 sh | $66.10 | $1,101,820.9 | −4.2% | |
ANIP | Open-market sale | 24/03/06–24/03/08 | 24/03/08 | 45,257 sh2 trades | $66.10avg. | $2,991,468.76 | −9.9% |
ANIP | Open-market sale | 23/08/11–23/08/15 | 23/08/15 | 68,282 sh2 trades | $58.32avg. | $3,982,547.58 | −16.2% |